(Q35337607)

English

Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

Marcus Hompesch

2

object named as

Marcus Hompesch

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Andreas Pfützner

7

object named as

Andreas Pfützner

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1

object named as

Lutz Heinemann

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Frank Flacke

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Patrick Simms

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Rody Pohl

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Kerstin Albus

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Solomon Steiner

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Journal of Diabetes Science and Technology

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

681-686

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

27 July 2018

Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

27 July 2018

Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

27 July 2018

Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

26 September 2018

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

26 September 2018

Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

26 September 2018

A novel insulin formulation with a more rapid onset of action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

26 September 2018

Injection-meal interval: recommendations of diabetologists and how patients handle it.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192634

26 September 2018

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21722583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21722583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21722583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal

1 reference

https://pubmed.ncbi.nlm.nih.gov/21722583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/193229681100500322

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35337607&oldid=1576325190"